$278 Million is the total value of Krensavage Asset Management, LLC's 20 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP | $29,154,000 | +17.1% | 275,248 | +23.2% | 10.50% | +17.6% |
| OFIX | Buy | ORTHOFIX INTERNATIONAL NV | $27,409,000 | +2.6% | 646,446 | +0.5% | 9.88% | +3.1% |
| IPXL | Buy | IMPAX LABORATORIES INC | $21,062,000 | +11.9% | 730,817 | +24.3% | 7.59% | +12.4% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $19,998,000 | -22.8% | 906,930 | +2.8% | 7.20% | -22.5% |
| TEVA | Buy | TEVA PHARMACEUTICAL-SP ADR | $19,918,000 | -5.7% | 396,545 | +0.5% | 7.18% | -5.3% |
| Buy | AMGEN INC | $19,141,000 | +19.0% | 125,802 | +17.3% | 6.90% | +19.5% | |
| HYH | Buy | HALYARD HEALTH INC | $18,706,000 | +15.8% | 575,206 | +2.3% | 6.74% | +16.3% |
| SCMP | Buy | SUCAMPO PHARMACEUTICALS-CL A | $17,896,000 | +193.3% | 1,631,398 | +192.2% | 6.45% | +194.6% |
| Buy | INDIVIOR PLC | $15,800,000 | +43.4% | 4,727,970 | +0.5% | 5.69% | +44.0% | |
| CNMD | Buy | CONMED CORP | $15,710,000 | +14.4% | 329,142 | +0.5% | 5.66% | +14.9% |
| MRK | Buy | MERCK & CO. INC. | $14,837,000 | +9.4% | 257,538 | +0.5% | 5.35% | +9.9% |
| RTIX | Buy | RTI SURGICAL INC | $13,096,000 | -5.0% | 3,648,001 | +5.8% | 4.72% | -4.6% |
| SHPG | New | SHIRE PLC-ADR | $11,628,000 | – | 63,166 | +100.0% | 4.19% | – |
| IVC | Buy | INVACARE CORP | $10,934,000 | +35.8% | 901,440 | +47.4% | 3.94% | +36.4% |
| AGN | Buy | ALLERGAN PLC | $6,104,000 | -13.3% | 26,416 | +0.6% | 2.20% | -12.9% |
| DEPO | Sell | DEPOMED INC | $4,275,000 | -31.3% | 217,904 | -51.3% | 1.54% | -31.1% |
| New | AVIRAGEN THERAPEUTICS INC | $3,791,000 | – | 2,708,438 | +100.0% | 1.37% | – | |
| DSCI | Buy | DERMA SCIENCES INC | $3,588,000 | +27.7% | 910,703 | +0.5% | 1.29% | +28.3% |
| DRAD | Buy | DIGIRAD CORP | $2,478,000 | +4.3% | 481,218 | +0.5% | 0.89% | +4.8% |
| JNP | Buy | JUNIPER PHARMACEUTICALS INC | $2,017,000 | +6.3% | 287,755 | +0.3% | 0.73% | +6.8% |
| HRC | Exit | HILL-ROM HOLDINGS INC | $0 | – | -34,442 | -100.0% | -0.62% | – |
| Exit | BIOTA PHARMACEUTICALS INC | $0 | – | -2,694,601 | -100.0% | -1.45% | – | |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -1,092,162 | -100.0% | -2.49% | – |
| BXLT | Exit | BAXALTA INC | $0 | – | -734,885 | -100.0% | -10.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.